Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kala Pharmaceuticals Inc

KALA
Current price
5.2 USD -0.6 USD (-10.34%)
Last closed 5.75 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 645 539 USD
Yield for 12 month -65.29 %
1Y
3Y
5Y
10Y
15Y
KALA
21.11.2021 - 28.11.2021

KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. Address: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+3 892 000 USD

Current Quarter

Last Quarter

+70 000 USD

Current Year

-303 000 USD

Last Year

+1 332 000 USD

Current Quarter

-66 000 USD

Last Quarter

Key Figures KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 568 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -40.78 %
PEG Ratio
Return On Equity TTM -262.61 %
Wall Street Target Price 18.33 USD
Revenue TTM
Book Value 2.37 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 1 332 000 USD
Earnings per share -14.56 USD
Diluted Eps TTM -14.56 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KALA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 21.10.2022
Dividend Date

Stock Valuation KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.0421
Price Sales TTM 1.157
Enterprise Value EBITDA -0.1582
Price Book MRQ 2.7024

Financials KALA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KALA

For 52 weeks

5.1 USD 16.32 USD
50 Day MA 6.62 USD
Shares Short Prior Month 6 029
200 Day MA 7.45 USD
Short Ratio 0.71
Shares Short 7 667
Short Percent 0.23 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics